Anadolu Medical Center
Bacillus Calmette-Guérin (BCG) therapy in Turkey typically costs from AUD $1,741 to AUD $3,191 per session. Total pricing depends on the treatment induction phase, clinic accreditation, and diagnostic requirements. Patients save around 0% compared to Australia, where average costs are AUD $1,741. Standard protocols usually include oncology consultations, the therapeutic agent, and follow-up monitoring. Major medical hubs include Istanbul, Antalya, and Bursa.
Bookimed Expert Insight: Choosing a clinic with international ties can provide exceptional value for Australian patients. For example, Anadolu Medical Center is affiliated with Johns Hopkins Medicine and holds OECI accreditation. This ensures adherence to top-tier oncology protocols without the premium Australian private fees. Specialists like Dr. Ilker Tinay, who sits on international bladder cancer boards, offer specialized expertise at a fraction of the cost found in Sydney or Melbourne.
| Turkey | Thailand | ||
| Bacillus Calmette-Guérin (BCG) therapy | from AUD $1,741 | from AUD $2,176 | from AUD $1,741 |
Dr. Mustafa Solak is a clinical oncologist at Hisar Hospital Intercontinental in Istanbul. He completed a fellowship at the prestigious Hacettepe University Cancer Institute. Dr. Solak previously practiced at The University of Texas MD Anderson Cancer Center. He treats a variety of complex cancers, including lung, breast, and gastrointestinal malignancies.
Dr. Ilker Tinay is an urological oncologist at Anadolu Medical Center. He sits on the Executive Board of the Association of Urooncology. Dr. Tinay specializes in minimally invasive surgery and neo-bladder reconstruction. He works at Anadolu, a Top 10 global hospital according to MTQUA. The center is also affiliated with Johns Hopkins Medicine.
Professor Alemdar is a medical oncology specialist at Medical Park Antalya with deep expertise in managing urological cancers through immunotherapy and targeted treatments.
Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.